BMJ  2008;336:1281-1283 (7 June), doi:10.1136/bmj.39569.510521.AD

Analysis

Complex interventions or complex systems? Implications for health economic evaluation

Alan Shiell, professor1, Penelope Hawe, professor1, Lisa Gold, senior research fellow2

1 Population Health Intervention Research Centre, University of Calgary, Calgary T2N 4N1, Canada , 2 Health Economics Unit, School of Health and Social Development, Deakin University, Melbourne, Australia

Correspondence to: A Shiell ashiell@ucalgary.ca

Although guidelines exist for evaluating complex interventions, they may be of little help in dealing with the multiple effects of interventions in complex systems such as hospitals. Alan Shiell, Penelope Hawe, and Lisa Gold explain why it is important to distinguish the two types of complexity

The first 150 words of the full text of this article appear below.

Health researchers commonly use the notion of complexity to indicate the problems faced in evaluating the effectiveness of many non-drug interventions.1 2 3 However, although it is rarely delineated, complexity has two meanings. In the first it is a property of the intervention, and in the second it is a property of the system in which the intervention is implemented. We examine the implications of these two views for economic evaluation.

What do we mean by complex?

The first view of complexity, in effect, means complicated. This is the meaning used in the Medical Research Council’s framework for the evaluation of complex interventions.4 5 A complex intervention is "built up from a number of components, which may act both independently and inter-dependently."4 This makes it hard to define the "active ingredients" and to be sure which component or combinations of components is more important.

The second view makes reference to the insights offered by complexity science.6 7 8 9 Complexity is a . . . [Full text of this article]

Implications for economic evaluation

What should we evaluate?


How should we evaluate benefits?


New approaches?


Summary points

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Complexity theory
Tony Delamothe
BMJ 2008 336: 0. [Extract] [Full Text]

Should we use large scale healthcare interventions without clear evidence that benefits outweigh costs and harms? Yes
Bernard Crump
BMJ 2008 336: 1276. [Full Text] [PDF]

Should we use large scale healthcare interventions without clear evidence that benefits outweigh costs and harms? No
C Seth Landefeld, Kaveh G Shojania, and Andrew D Auerbach
BMJ 2008 336: 1277. [Full Text] [PDF]

Designing and evaluating complex interventions to improve health care
Neil C Campbell, Elizabeth Murray, Janet Darbyshire, Jon Emery, Andrew Farmer, Frances Griffiths, Bruce Guthrie, Helen Lester, Phil Wilson, and Ann Louise Kinmonth
BMJ 2007 334: 455-459. [Extract] [Full Text] [PDF]

Process evaluation in randomised controlled trials of complex interventions
Ann Oakley, Vicki Strange, Chris Bonell, Elizabeth Allen, Judith Stephenson RIPPLE Study Team
BMJ 2006 332: 413-416. [Full Text] [PDF]

Complex interventions: how "out of control" can a randomised controlled trial be?
Penelope Hawe, Alan Shiell, and Therese Riley
BMJ 2004 328: 1561-1563. [Extract] [Full Text] [PDF]

Complexity science: The challenge of complexity in health care
Paul E Plsek and Trisha Greenhalgh
BMJ 2001 323: 625-628. [Extract] [Full Text] [PDF]

Framework for design and evaluation of complex interventions to improve health
Michelle Campbell, Ray Fitzpatrick, Andrew Haines, Ann Louise Kinmonth, Peter Sandercock, David Spiegelhalter, and Peter Tyrer
BMJ 2000 321: 694-696. [Extract] [Full Text] [PDF]


Online poll
Find out more

Rapid responses for this article

There are no rapid responses for this article.


Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview